Tag: US Market
Each warrant authorises the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable.
The offering was expected to close on June 30, 2020, subject to customary closing conditions.
Kensington Capital Acquisition V, a blank check business run by Kensington Capital’s founder and focused on industrials, filed with the SEC on Monday to raise up to $260 million.
The business, situated in Westbury, New York, hopes to generate $260 million by selling 26 million units at $10 each. One share of common stock and one-fifth of a warrant, exercisable at $11.50, are included in each unit. Kensington Capital Acquisition V would have a market value of $325 million at the anticipated deal size.
Company Profile
Kensington Capital Acquisition V was founded in 2021 and plans to list on the NYSE under the symbol KCGI.U. The company filed confidentially on June 10, 2021. UBS Investment Bank is the sole bookrunner on the deal. Kensington Capital Acquisition Corp. II operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
(Source: NASDAQ.com)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
One common share and three-quarters of a common share purchase warrant are included in each Unit. Each Warrant authorises the holder to purchase one common share at a price of US$2.10 per common share for a period of 60 months following the closure of the Offering, subject to adjustment in certain conditions.
The Offering is scheduled to close on or around July 20, 2021, with the common shares underlying the Units and Warrants proposed for listing on the TSX and Nasdaq.
The Corporation plans to use the net proceeds of the Offering to continue clinical development of maveropepimut-S (DPX-Survivac) in DLBCL, breast cancer, ovarian cancer, bladder cancer, and microsatellite instability high (MSI-H), as well as to begin clinical development of a new product, DPX-SurMAGE, in bladder cancer, continuing to develop its patented drug delivery technology (DPX), as well as for other corporate reasons.
Company Profile
Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden. We were spun out from AstraZeneca in 2008.
(Source: RTT News)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
In March 2011, the company went public, raising $290 million, before being acquired and taken private by Apollo Global Management for $1.4 billion in 2016.
On March 12, 2021, The Fresh Market filed a confidential filing. The deal’s joint book runners are Credit Suisse, BofA Securities, Barclays, Deutsche Bank, RBC Capital Markets, BMO Capital Markets, Guggenheim Securities, and Apollo Global Securities. There were no pricing details provided.
Company Profile
The Fresh Market offers high-quality, fresh goods and hard-to-find items in a small, intimate store with great cleanliness and high-touch guest care. It is an Apollo-backed fresh food supermarket with over 150 locations in 22 states.
(Source: NASDAQ.com)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
The Beverly Hills, California-based company was created in 2016 and has revenue of $8 million for the year ending March 31, 2021. It intends to trade under the symbol “EVMO” on the NASDAQ. The deal’s sole book runner is Think Equity. There were no pricing details provided.
Company Profile
EVmo, Inc. connects rideshare drivers in need of a suitable car with rideshare firms that rely on attracting and retaining drivers. It operates primarily in Rideshare Car Rentals and Distinct Cars, two wholly-owned subsidiaries. Rideshare has an online reservation system. Customers who are drivers in the ridesharing and delivery gig industries can rent a fleet of passenger vehicles and transit vans for usage in the last-mile logistical space from Distinct Cars, which also provides them with insurance coverage and issues them insurance cards in their own names.
(Source: NASDAQ)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
One share of common stock, one right to earn one-tenth of a share upon completion of an initial business combination, and one warrant, exercisable at $11.50, are included in each unit.
Bannix Acquisition will raise -50% less money under the new deal size than it had planned.
Company Profile
Bannix Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on B2B enterprise software companies, particularly those operating in the Customer Engagement space within the telecom, retail and financial services sectors. We will target businesses located in North America and Western Europe, ideally those with a recurring revenue model and an overall transaction value of at least $400 million.
(Source: NASDAQ.com)
General Advice Warning
Any advice/ information provided is general in nature only and does not take into account the personal financial situation, objectives or needs of any particular person.
